| Long name: |
MARVELD1 Primary Polyclonal Antibody |
| Also known as: |
MARVELD1 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
MARVELD1 |
| Specificity: |
This is a highly specific antibody against MARVELD1 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human MARVELD1 |
| Gene ID number: |
83742 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
(MARVEL domain-containing 1), It is a nuclear-localized protein that is widely expressed in normal human tissues, MARVELD1 protein levels are generally lower in several primary tumors including ovary, This lower level of MARVELD1 expression in tumors is thought to be due to a higher methylation status of the MARVELD1 promoter as treatment of MDA-MB-361 with 5-aza-2'-deoxycytidine restores MARVELD1 expression, While it has been reported to be overexpressed in colon cancer, bladder and liver, breast, is one of the MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain-containing proteins, kidney, suggesting that loss of MARVELD1 expression may contribute to tumorgenicity, MARVELD1 |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
MALD1_HUMAN, MARVD1, MARVEL domain containing protein 1, MARVEL membrane-associating domain containing 1, MRVLDC1, Putative MARVEL domain containing protein 1, GB14 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
MARVELD1 |
| Short name: |
MARVELD1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
MARVELD1 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
28674 |
| Gene: |
MARVELD1 |
More about : MARVELD1 |
| Long gene name: |
MARVEL domain containing 1 |
| Synonyms gene: |
MRVLDC1 |
| Synonyms gene name: |
MARVEL (membrane-associating) domain containing 1 |
| Synonyms: |
MGC4415 GB14 FLJ23440 FLJ22343 bA548K23, 8 |
| Locus: |
10q24, 2 |
| Discovery year: |
2004-03-05 |
| GenBank acession: |
BC004995 |
| Entrez gene record: |
83742 |
| Pubmed identfication: |
12477932 |
| RefSeq identity: |
NM_031484 |
| Havana BLAST/BLAT: |
OTTHUMG00000018865 |